Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma
Clinical trial NCT02410733 · COMPLETED
Trial details
- NCT number
- NCT02410733
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2023-06-20
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.